GB0605462D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0605462D0
GB0605462D0 GBGB0605462.1A GB0605462A GB0605462D0 GB 0605462 D0 GB0605462 D0 GB 0605462D0 GB 0605462 A GB0605462 A GB 0605462A GB 0605462 D0 GB0605462 D0 GB 0605462D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0605462.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0605462.1A priority Critical patent/GB0605462D0/en
Publication of GB0605462D0 publication Critical patent/GB0605462D0/en
Priority to PCT/EP2007/052478 priority patent/WO2007107499A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0605462.1A 2006-03-17 2006-03-17 Novel compounds Ceased GB0605462D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0605462.1A GB0605462D0 (en) 2006-03-17 2006-03-17 Novel compounds
PCT/EP2007/052478 WO2007107499A1 (en) 2006-03-17 2007-03-15 Quinoline derivatives useful as pde4 inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0605462.1A GB0605462D0 (en) 2006-03-17 2006-03-17 Novel compounds

Publications (1)

Publication Number Publication Date
GB0605462D0 true GB0605462D0 (en) 2006-04-26

Family

ID=36293009

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0605462.1A Ceased GB0605462D0 (en) 2006-03-17 2006-03-17 Novel compounds

Country Status (2)

Country Link
GB (1) GB0605462D0 (en)
WO (1) WO2007107499A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2379076B1 (en) * 2008-12-23 2014-11-12 The Trustees of Columbia University in the City of New York Phosphodiesterase inhibitors and uses thereof
AU2011253203A1 (en) 2010-05-10 2012-11-22 Gilead Sciences, Inc. Bifunctional quinoline derivatives
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
CA2900302C (en) 2013-02-19 2018-07-03 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
EP3172210B1 (en) 2014-07-24 2020-01-15 Pfizer Inc Pyrazolopyrimidine compounds
EP3177624B1 (en) 2014-08-06 2019-05-01 Pfizer Inc Imidazopyridazine compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
GB0322726D0 (en) * 2003-09-27 2003-10-29 Glaxo Group Ltd Compounds
GB0322722D0 (en) * 2003-09-27 2003-10-29 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2007107499A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
EP2034838A4 (en) Novel compounds
EP2032142A4 (en) Novel compounds
EP1981596A4 (en) Novel compounds
GB0603550D0 (en) Novel compounds
GB0609962D0 (en) Novel compounds
EP1981900A4 (en) Novel compounds
GB0605462D0 (en) Novel compounds
GB0602900D0 (en) Novel Compounds
GB0609117D0 (en) Novel compounds
GB0609963D0 (en) Novel compounds
EP2031965A4 (en) Novel compounds
GB0607840D0 (en) Novel compounds
GB0600483D0 (en) Novel compounds
GB0609252D0 (en) Novel sytoprotective compounds
GB0608452D0 (en) Novel compounds
GB0607892D0 (en) Novel compounds
GB0601294D0 (en) Novel compounds
GB0606526D0 (en) Novel compounds
GB0605463D0 (en) Novel compounds
GB0604897D0 (en) Novel compounds
GB0601728D0 (en) Novel Compounds
GB0607736D0 (en) Novel compounds
GB0607529D0 (en) Novel compounds
GB0607353D0 (en) Novel Compounds
GB0607896D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)